Public list Pharma Startups (4732):
CoPlex Therapeutics is focused on R&D to provide neuroprotection from dementia caused by a protein complex that accumulates in the central nervous system and begins the cascade effect that leads to dementia including Alzheimer's.
Company (Alive / Active)
Kentucky, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)